Cereno Scientific
BioStock: Cereno's CEO - "CS014 adds potential for cardiovascular disease patients"
Read the interview at biostock.se:
Cereno's CEO: "CS014 adds potential for cardiovascular disease patients" - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
Datum | 2024-06-20, kl 07:46 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)